$EVGN

Evogene Ltd

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$0.77 -

Delayed Price

VOLUME

4,685

DAY RANGE

- 0.77

52 WEEK

0.7 - 3.58

Join Discuss about EVGN with like-minded investors

profile
@dros #droscrew
recently

+Initiations 10/8: $ALLE $AQB $BBDC $BIOX $CELC $CTRE $CTVA $DDL $EVGN $GLW $INSM $JCI $OHI $OMF $PH $RSLS $SBRA $SKIN $SMFR $SWK $WMPN . -Initiations 10/8: $DOV $OTIS $ROK $TT

75 Replies 14 👍 15 🔥

profile
@dros #droscrew
recently

this $EVGN might be a cheap buy and hold

82 Replies 11 👍 11 🔥

Key Metrics

Market Cap

31.71 M

Beta

1.09

Avg. Volume

110.29 K

Shares Outstanding

41.19 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-10

Next Dividend Date

Company Information

Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., seed traits through the Ag-Seeds division, and ag-solutions for castor oil production through Casterra Ltd.

Website:

HQ: ,

Related News